USANA Health Sciences (USNA) said Monday the clinical study for its skin treatment Celavive Resurfacing Serum showed statistically significant improvements in the users' skin appearance and was well tolerated by all subjects.

The clinical study, which was done over 12 weeks to assess the efficacy and tolerance of the product, included 33 women with mild to moderate skin concerns, the company said.

Price: 24.77, Change: +0.03, Percent Change: +0.12